H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)

December 2, 2025 6:44 AM UTC Send to a Friend
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $12.00 price target on Dare Bioscience (NASDAQ: DARE).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login